Literature DB >> 15235166

Prevalence of human immunodeficiency virus infection in children with tuberculosis.

T Shahab1, M S Zoha, M Ashraf Malik, Abida Malik, K Afzal.   

Abstract

This prospective study was carried out in the pediatric ward and outpatient department of a tertiary care centre to estimate the prevalence of HIV seropositivity in children with tuberculosis. Two hundred and fifty consecutive children below 12 years of age with (pulmonary and extrapulmonary) tuberculosis diagnosed between March 1999 and July 2000 were screened for HIV infection. A patient was labeled as HIV positive if two consecutive ELISA tests were found positive using different antigen/principle. Supplemental western blot test was also done. Parents of seropositive children were also screened for HIV infection and tuberculosis. Total 5 cases were HIV positive giving a seroprevalence of 2%. All the five patients had disseminated tuberculosis. We suggest regular screening of children with disseminated/miliary tuberculosis for HIV co-infection.

Entities:  

Mesh:

Year:  2004        PMID: 15235166

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  4 in total

1.  Profile and outcome of childhood tuberculosis treated with DOTS--an observational study.

Authors:  Pushpa Panigatti; Vinod Hanumant Ratageri; Illalu Shivanand; P K Madhu; T A Shepur
Journal:  Indian J Pediatr       Date:  2013-07-28       Impact factor: 1.967

Review 2.  Recent advances in the diagnosis of childhood tuberculosis.

Authors:  Ben J Marais; Madhukar Pai
Journal:  Arch Dis Child       Date:  2007-05       Impact factor: 3.791

3.  Prevalence of pediatric HIV in New Delhi.

Authors:  P Parthasarathy; S K Mittal; V K Sharma
Journal:  Indian J Pediatr       Date:  2006-03       Impact factor: 5.319

Review 4.  The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.

Authors:  P J Dodd; A J Prendergast; C Beecroft; B Kampmann; J A Seddon
Journal:  Thorax       Date:  2017-01-23       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.